• Equity PC Ratio   0.57
  • |
  • Index PC Ratio   1.14
  • |
  • Total PC Ratio   0.97
  • |
  • VIX PC Ratio   0.54
  • VIX 14.44
  • VXN 18.58
  • VXO 14.45
  • ISEE 85.00

TruCharts Trading Strategies and Stock Buy/Sell Reports
(Show Details)


Chart Settings
No saved settings found!

Chart Type:
From: / / To: / /
Show detail in :
 Chart Skins:      
Price Overlays:





Indicator Windows:





Company Profile

Rockwell Medical Technologies, Inc. manufactures and sells hemodialysis concentrate solutions and dialysis kits to hemodialysis providers, targeting end-stage renal disease, chronic kidney disease, and iron deficiency anemia in the United States and internationally. It manufactures, sells, distributes, and delivers hemodialysis concentrates, as well as a line of ancillary hemodialysis products to hemodialysis providers and distributors located in 37 states and territories, as well as various countries, primarily in Latin America, Asia, and Europe. Hemodialysis duplicates kidney function in patients with failing kidneys, known as end stage renal disease, an advanced stage of chronic kidney disease characterized by the irreversible loss of kidney function. It offers Renal Pure liquid acid concentrates, Dri-Sate dry acid concentrate and mixing system, RenalPure powder bicarbonate concentrate, and SteriLyte liquid bicarbonate concentrate, as well as a range of ancillary products, including blood tubing, fistula needles, specialized custom kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. Rockwell Medical Technologies sells its products through direct salespeople and independent sales representation companies; and to certain international customers through independent sales agents and distributors. The company was founded in 1995 and is based in Wixom, Michigan.

NO
     
()
Last Trade Date
Change % Price Change
Open 52 Week High
High 52 Week Low
Low Type
Volume Average Volume
Prev Close Stock Exchange
Bid Ask
Bid Size Ask Size
1st Yr Estimated EPS Growth 2nd Yr Estimated EPS Growth
2 Years Forward Earning Yield 2 Years Forward PE Ratio
2 Years EV/Forward EBIT 2 Years EV/Forward EBITDA
Book Value per Share Book Value Yield
Buy Back Yield CAPE Ratio
Cash Return Cash Flow per Share
Cash Flow Yield Dividend Rate
Dividend Yield 5 Year Dividend Yield
Earning Yield EV/EBIT
EV/EBITDA EV / Free Cash Flow
EV / Forward EBIT EV / Forward EBITDA
EV / Forward Revenue EV / Pre Tax Income
EV / Revenue EV / Total Asset
Expected Dividend Growth Rate Free Cash Flow per Share
Free Caash Flow Ratio Free Cash Flow Yield
Forward Calculation Style Forward Dividend Yield
Forward Earning Yield Forward PE Ratio
Forward Return on Asset Forward Return on Equity
Normalized PE Ratio Payout Ratio
PB Ratio PB Ratio 10 Year Growth
PB Ratio 3 Year Growth Cash Ratio 3 Year Average
Price to Cash Flow Ratio PEG Payback
PEG Ratio PE Ratio
PE Ratio 10 Year Average PE Ratio 10 Year Growth
PE Ratio 10 Year High PE Ratio 10 Year Low
PE Ratio 1 Year Avg PE Ratio 1 Year High
PE Ratio 1 Year Low PE Ratio 3 Year Avg
PE Ratio 5 Year Avg PE Ratio 5 Year High
PE Ratio 5 Year Low Free Cash Flow Ratio 10 Year Growth
Free Cash Flow Ratio 3 Year Avg Price Change 1 Month
Price to Cash Ratio Price / EBITDA
Price to Sales Ratio Price to Sales Ratio 10 Year Growth
Price to Sales Ratio 3 Year Avg Price to Sales Ratio 5 Year Avg
Sale per Share Sales Yield
Sustainable Growth Rate Tangible Book Value per Share
Tangible Book Value per Share 3 year Avg Tangible Book Value per Share 5 year Avg
Total Asset per Share Total Yield
Working Capital per Share Working Capital per Share 3 Year Avg
Working Capital per Share 5 Year Avg Beta